Studies conducted in 2014 concluded that by stimulating the innate immune system via the Dectin-1 signaling pathway, β–glucans might be exploited by modulating the action of T cells responsible for destruction of insulin-producing pancreatic β–cells, and thus it can ensure a long-term protection of pancreatic β–cells in diabetes type I [19]. Here, INS is linked to type 1 diabetes mellitus.